Opt‐out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta‐analysis. Issue 6 (21st December 2016)

• Record Type: Journal Article
• Authors: Henriquez‐Camacho, C; Villafuerte‐Gutierrez, P; Pérez‐Molina, JA; Losa, J; Gotuzzo, E; Cheyne, N
• Is Part Of: HIV medicine. Volume 18:Issue 6(2017:Jul.)
• Page Start: 419
• Page End: 429
• Publication Date: 2016-12-21
• Subjects: diagnosis -- emergency departments -- HIV -- opt‐in -- opt‐out -- screening; HIV infections -- Treatment -- Periodicals; HIV-positive persons -- Periodicals; HIV infections -- Treatment -- Decision making -- Periodicals; 616.9792
• DOI: 10.1111/hiv.12474
• Languages: English
• ISSNs: 1464-2662

Abstract

Abstract : Objectives: International health agencies have promoted nontargeted universal (opt‐out) HIV screening tests in different settings, including emergency departments (EDs). We performed a systematic review and meta‐analysis to assess the testing uptake of strategies (opt‐in targeted, opt‐in nontargeted and opt‐out) to detect new cases of HIV infection in EDs. Methods: We searched the Pubmed and Embase databases, from 1984 to April 2015, for opt‐in and opt‐out HIV diagnostic strategies used in EDs. Randomized controlled or quasi experimental studies were included. We assessed the percentage of positive individuals tested for HIV infection in each programme (opt‐in and opt‐out strategies). The mean percentage was estimated by combining studies in a random‐effect meta‐analysis. The percentages of individuals tested in the programmes were compared in a random‐effect meta‐regression model. Data were analysed usingstata version 12. Quality assessments were performed using the Newcastle−Ottawa Scale. Results: Of the 90 papers identified, 28 were eligible for inclusion. Eight trials used opt‐out, 18 trials used opt‐in, and two trials used both to detect new cases of HIV infection. The test was accepted and taken by 75 155 of 172 237 patients (44%) in the opt‐out strategy, and 73 581 of 382 992 patients (19%) in the opt‐in strategy. The prevalence of HIV infection detected by the opt‐out strategy was 0.40% (373 cases), that detected by the opt‐in nontargeted strategy was 0.52% (419 cases), and that detected by the opt‐in targeted strategy was 1.06% (52 cases). Conclusions: In this meta‐analysis, the testing uptake of the opt‐out strategy was not different from that of the opt‐in strategy to detect new cases of HIV infection in EDs.